114 related articles for article (PubMed ID: 24797918)
1. Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines.
Shoja Z; Tagliamonte M; Jalilvand S; Mollaei-Kandelous Y; De Stradis A; Tornesello ML; Buonaguro FM; Buonaguro L
J Med Virol; 2015 Jan; 87(1):102-11. PubMed ID: 24797918
[TBL] [Abstract][Full Text] [Related]
2. Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana.
Pêra FF; Mutepfa DL; Khan AM; Els JH; Mbewana S; van Dijk AA; Rybicki EP; Hitzeroth II
Virol J; 2015 Dec; 12():205. PubMed ID: 26626122
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
Lappalainen S; Tamminen K; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
[TBL] [Abstract][Full Text] [Related]
4. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles.
Li T; Lin H; Zhang Y; Li M; Wang D; Che Y; Zhu Y; Li S; Zhang J; Ge S; Zhao Q; Xia N
Vaccine; 2014 Apr; 32(17):1921-31. PubMed ID: 24530406
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of double-layered rotavirus-like particles using internal ribosome entry site vector system in stably-transformed Drosophila melanogaster.
Lee JM; Chung HY; Kim KI; Yoo KH; Hwang-Bo J; Chung IS; Park JH
Biotechnol Lett; 2011 Jan; 33(1):41-6. PubMed ID: 20820877
[TBL] [Abstract][Full Text] [Related]
6. Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes.
Peralta A; Molinari P; Taboga O
Virol J; 2009 Nov; 6():192. PubMed ID: 19891790
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.
Blazevic V; Malm M; Arinobu D; Lappalainen S; Vesikari T
Hum Vaccin Immunother; 2016 Mar; 12(3):740-8. PubMed ID: 26467630
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization.
Lopez-Guerrero DV; Arias N; Gutierrez-Xicotencatl L; Chihu-Amparan L; González A; Pedroza-Saavedra A; Rosas-Salgado G; Villegas-Garcia JC; Badillo-Godinez O; Fernandez G; Lopez S; Esquivel-Guadarrama F
Vaccine; 2018 May; 36(22):3072-3078. PubMed ID: 28465094
[TBL] [Abstract][Full Text] [Related]
9. Development of a stable insect cell line constitutively expressing rotavirus VP2.
Shoja Z; Tagliamonte M; Jalilvand S; Mokhtari-Azad T; Hamkar R; Shahmahmoodi S; Rezaei F; Tornesello M; Buonaguro FM; Buonaguro L; Nategh R
Virus Res; 2013 Mar; 172(1-2):66-74. PubMed ID: 23287060
[TBL] [Abstract][Full Text] [Related]
10. Production of hybrid double- or triple-layered virus-like particles of group A and C rotaviruses using a baculovirus expression system.
Kim Y; Chang KO; Kim WY; Saif LJ
Virology; 2002 Oct; 302(1):1-8. PubMed ID: 12429511
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of human group C rotavirus virus-like particles in insect cells.
Clark KB; Lin SC; Humphrey C; Foytich K; Esona M; Wang Y; Liu M; Jiang B
Virology; 2009 May; 387(2):267-72. PubMed ID: 19285329
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
Yang Y; Li X; Yang H; Qian Y; Zhang Y; Fang R; Chen X
Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
Dennehy M; Bourn W; Steele D; Williamson AL
Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
[TBL] [Abstract][Full Text] [Related]
14. Downstream processing of triple layered rotavirus like particles.
Peixoto C; Sousa MF; Silva AC; Carrondo MJ; Alves PM
J Biotechnol; 2007 Jan; 127(3):452-61. PubMed ID: 16959354
[TBL] [Abstract][Full Text] [Related]
15. Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.
Azevedo MP; Vlasova AN; Saif LJ
Expert Rev Vaccines; 2013 Feb; 12(2):169-81. PubMed ID: 23414408
[TBL] [Abstract][Full Text] [Related]
16. Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies.
Saldaña S; Esquivel Guadarrama F; Olivera Flores Tde J; Arias N; López S; Arias C; Ruiz-Medrano R; Mason H; Mor T; Richter L; Arntzen CJ; Gómez Lim MA
Viral Immunol; 2006; 19(1):42-53. PubMed ID: 16553549
[TBL] [Abstract][Full Text] [Related]
17. Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa.
Jere KC; O'Neill HG; Potgieter AC; van Dijk AA
PLoS One; 2014; 9(9):e105167. PubMed ID: 25268783
[TBL] [Abstract][Full Text] [Related]
18. Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity.
Charpilienne A; Lepault J; Rey F; Cohen J
J Virol; 2002 Aug; 76(15):7822-31. PubMed ID: 12097594
[TBL] [Abstract][Full Text] [Related]
19. Solubilized and cleaved VP7, the outer glycoprotein of rotavirus, induces permeabilization of cell membrane vesicles.
Charpilienne A; Abad MJ; Michelangeli F; Alvarado F; Vasseur M; Cohen J; Ruiz MC
J Gen Virol; 1997 Jun; 78 ( Pt 6)():1367-71. PubMed ID: 9191931
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
